Developing vaccines and antibodies to prepare for pandemics
Coordinating and Data Sharing Center - R&D of Vaccines and Antibodies for Pandemic Preparedness (ReVAMPP)
This study is working to bring together different research teams to create vaccines and treatments for new infectious diseases that could cause pandemics, so that patients can have better options and protection when facing future outbreaks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project ID | NIH-10856492 on NIH RePORTER |
What this research studies
This research focuses on creating a collaborative network aimed at developing vaccines and monoclonal antibodies to combat emerging infectious diseases, particularly those with pandemic potential. By integrating efforts from various research centers, the project seeks to enhance our understanding and response capabilities against high-risk viral families. Patients may benefit from the accelerated development of effective treatments and preventive measures against future pandemics, ensuring better health outcomes during viral outbreaks.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals at risk of exposure to emerging infectious diseases, such as healthcare workers and those with compromised immune systems.
Not a fit: Patients who are not at risk of infectious diseases or those with stable chronic conditions unrelated to viral infections may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the rapid availability of effective vaccines and treatments for future pandemics, improving public health safety.
How similar studies have performed: Previous research initiatives focused on pandemic preparedness have shown promise in developing effective vaccines and treatments, indicating that this approach has potential for success.
Where this research is happening
Research Triangle Park, United States
- Research Triangle Institute — Research Triangle Park, United States (Active)
Researchers
- Principal investigator: Sempowski, Gregory D — Research Triangle Institute
- Study coordinator: Sempowski, Gregory D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.